Chargement en cours...
Disruption of the AKT Pathway Inhibits Metastasis in an Orthotopic Model of Head and Neck Squamous Cell Carcinoma
INTRODUCTION: Merck's MK-2206 is an orally active, allosteric inhibitor of AKT; a component of the phosphatidylinositol-3 kinase (PI3K) pathway. The PI3K-AKT pathway is a downstream signaling pathway that has recently been found to play an important role in head and neck squamous cell carcinoma...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3396129/ https://ncbi.nlm.nih.gov/pubmed/22020886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/lary.22180 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|